日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study

玻璃体内注射抗血管内皮生长因子与新生血管性年龄相关性黄斑变性患者卒中风险的关系——一项基于登记队列的研究

Falemban, A H; Söderberg-Löfdal, K; Jonsson, F; Almlöf-Sarman, S; von Euler, M; Westborg, I

Faricimab versus bevacizumab for neovascular age-related macular degeneration: Cost analysis based on real-world data from the Swedish Macula Registry

法瑞西单抗与贝伐单抗治疗新生血管性年龄相关性黄斑变性:基于瑞典黄斑登记处真实世界数据的成本分析

Abdalla, Souad; Westborg, Inger; Pulkki-Brännström, Anni-Maria; Norberg, Helena

Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study

在真实世界糖尿病性黄斑水肿人群中评估法瑞西单抗的适应症:一项横断面研究

Westborg, Inger; Al-Najjar, Ayat; Norberg, Helena

What about the fellow eye in treatment of neovascular age-related macular degeneration? Analysis of data from the Swedish macula register

在治疗新生血管性年龄相关性黄斑变性时,另一只眼睛该如何处理?瑞典黄斑登记数据的分析

Lövestam Adrian, Monica; Schroeder, Marion; Westborg, Inger

Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)

在接受新生血管性年龄相关性黄斑变性(nAMD)治疗的6142只眼睛中,有12%在2年内出现视力预后不良。该分析来自瑞典黄斑登记处(SMR)。

Schroeder, Marion; Westborg, Inger; Lövestam Adrian, Monica

Follow-Up After Cataract Surgery - Comparison of the Practice in Two Institutions with the Aim of Optimize the Routine

白内障手术后随访——两家机构实践比较及优化常规流程

Westborg, Inger; Mönestam, Eva

Intracameral anesthesia for cataract surgery: a population-based study on patient satisfaction and outcome

白内障手术中前房麻醉:一项基于人群的患者满意度和疗效研究

Westborg, Inger; Mönestam, Eva